Navigation Links
Pennsylvania Law Firm Urges FDA Action On Power Morcellators
Date:7/16/2014

Philadelphia, PA (PRWEB) July 16, 2014

The law firm of Levy, Baldante, Finney, Rubenstein, Cohen & Chizmar, P.C. recognizes the deep-seated concerns shared by many in regard to laparoscopic power morcellator devices intended for use in various types of uterine surgeries, including hysterectomies and myomectomies, and on the heels of a Food and Drug Administration advisory panel meeting, it's asking the FDA to do the same. The hearings concerned a device currently being assessed for its propensity to spread uterine cancer to other portions of the body.

This past April, the FDA warned doctors against using these morcellator devices to conduct an operation, at the time requesting new labels that would delineate the potential risk to patients (FDA NEWS RELEASE, 4/17/14). Johnson & Johnson’s Ethicon unit subsequently halted the sale and distribution of the morcellators.

The FDA panel (NEJM Journal Watch, "FDA Advisers Call for Black-Box Warning or All-Out Ban on Morcellators in Fibroid Removal," 7/14/14) was intended to give the agency a clearer idea of the risks of the device and the best course of action. While the advisory panel failed to reach a consensus, there were signals from many participants that a future halt on usage might be in the offing, with the majority opinion that morcellators should be banned or at the very least limited. This insight came after a set of hearings in which doctors spoke on the matter and people affected by a surgery gone wrong shared their plight.

Levy Baldante Finney Baldante Rubenstein & Cohen is asking the FDA to follow the lead of those advisory panel members who recognized the inherent danger posed by these uterine surgery devices. They ask that the FDA ban the further sale and usage of morcellators for uterine surgery.

The New Jersey and Pennsylvania personal injury law firm’s medical device liability branch has taken an active interest in the subject and is working to assist people who have been negatively impacted by these products. Martin G. Rubenstein, the firm’s lead on Drug and Medical Device litigation, had this to say:

“Early word out of the morcellator advisory panel is encouraging,” said Mr. Rubenstein, “but in the past, I’ve seen various instances where the FDA’s final decision does not align with what concerned panel members have urged. It’s more important than ever that the FDA take a look at the facts and come to a wise decision regarding the usage of these devices.

“In order to offer the highest degree of protection to citizens, the FDA should move to put an end to the sale of morcellators and initiate an immediate recall on the items. At the very least, new usage guidelines must be put in place that prevent the products’ continued usage except in extreme cases where immediate medical intervention is necessary and a doctor has been able to rule out the presence of uterine sarcomas. In such instances, a patient must be made well aware of the potential dangers.”

“It’s my sincere hope that the FDA acts at once so that no one else has to be put at risk by these devices.”

The law firm of Levy, Baldante, Finney, Rubenstein, Cohen & Chizmar, P.C. has been fighting for the rights of injured parties since its founding in the 1960s. Recognized by such organizations as Super Lawyers, the American Association for Justice, and the Trial Lawyers Associations of both Pennsylvania and New Jersey, Levy Baldante is dedicated to assisting persons injured by medical malpractice, automobile accidents, defective products, premises liability, and other instances of personal injury. A host of personal injury resources and a free consultation are available via the firm’s Laparoscopic Power Morcellator Uterine Surgery Lawsuit webpage.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12017413.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. SeniorQuote Insurance Services Expands Coverage to Pennsylvania
2. As Risperdal Lawsuits Move Forward, Wright & Schulte LLC Learns of Bid to Keep Clinical Studies Sealed in Pennsylvania Risperdal Litigation
3. Pennsylvania Athletic Trainers’ Society (PATS) and Pennsylvania Society of Physician Assistants Meet: Discuss Issues to Improve Quality of Healthcare for Athletes
4. National Conservative Group Begins Pennsylvania Ad Blitz -- Starts Ads on the Heels of Failed Obamacare Rollout, Tax Increase Push
5. Workers’ Compensation Costs Per Claim Moderating In Pennsylvania After Years of Growth, New Study Reports
6. Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Mounting Claims Involving Risperdal Gynecomastia Allegations in Pennsylvania Litigation
7. Pradaxa Lawsuits Continue to Mount, With Filing of New Pradaxa Wrongful Death Claim in Pennsylvania by Wright & Schulte LLC
8. What Does the New Breast Density Bill Mean for Pennsylvania Women?
9. American Banker Honors Patti Husic, Centric Bank CEO and Chair of Pennsylvania Bankers Association, as One of The 25 Women to Watch in U.S. Banking
10. New Risperdal Lawsuit Filed in Pennsylvania Litigation; Alleges Male Breast Growth Injuries Caused by Anti-Psychotic Medication, Bernstein Liebhard LLP Reports
11. Pennsylvanians Want Full Liquor Privatization; Survey Shows Strong Bipartisan Support, Including Among Union Households
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... County, CA (PRWEB) , ... February 27, 2017 , ... ... periodontitis. Periodontitis is a chronic inflammatory gum condition that occurs when the bacteria in ... deep cleaning, also referred to as a scaling and root planing or SRP, and ...
(Date:2/27/2017)... TX (PRWEB) , ... February 27, 2017 , ... ... 75,000 customer threshold mark last week. In addition, Discount Power's RCE (Residential Customer ... Energy LLC in March 2014. The company had 800 customers and 2,250 RCEs ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... New Jersey ... rates, among all types and genders. And the need for advanced services is growing. ... and its top-rated cancer care program, in collaboration with their non-profit partners in their ...
(Date:2/26/2017)... ... February 26, 2017 , ... NuevaCare, a leading home care ... Millbrae, Belmont, and Palo Alto, is proud to announce an important upgrade to its ... look for home care close to home, and by having city-specific pages, NuevaCare is ...
(Date:2/26/2017)... (PRWEB) , ... February 26, 2017 , ... ODH, Inc.™ ... Care Summit, February 27-28 at the Sheraton Pentagon City Hotel in Arlington, VA. ODH’s ... PerformCARE to use behavioral health analytics to improve Medicaid population health management. , ODH ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 24, 2017 Juan Monteverde ... Associates PC , a boutique securities firm headquartered at ... City , announces that a class action lawsuit ... Massachusetts  against Inotek Pharmaceuticals Corporation (NASDAQ:  ITEK)("Inotek" ... Company,s securities between July 23, 2015 and December 30, 2016, ...
(Date:2/24/2017)... MELBOURNE , Australien, 24. Februar 2017 /PRNewswire/ ... innovatives, diversifiziertes Unternehmen des Gesundheitsbereiches, ist erfreut, für ... Vergleich mit dem entsprechenden Vorjahreszeitraum exzellente Ergebnisse vorlegen ... BioMedical und Aktualisierung zum Wachstum" finden Sie ... Gewinn nach Steuern 2,12 Millionen USD (Dez. 2015: ...
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017  This ... US$ Thousand by the following Products: ... analyzed in the report include Pharmaceuticals, and Agrochemicals. The ... Japan , Europe , ... provided for the period 2015 through 2022. Also, a ...
Breaking Medicine Technology: